To further unravel the potential predictive value of PCSK9 gene alterations for ICI treatment, we then investigated the relationship between PCSK9 alterations and six common immune infiltrates (B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrophils, and DCs) across multiple cancer types. The gene discussed is CD4; the disease is cancer.